Heard at ISPOR: Wide Ranging Podcast with IVI on Advanced Value Assessment Methods and the QALY Controversy

IVI team sat down with the Journal of Clinical Pathways while at ISPOR for an in-depth discussion about why advanced value assessment is needed and how it’s progressing. The team also discussed the QALY – what it is and whether it can be improved. To listen to the podcast or read the transcript, click here.
IVI Comments on ICER’s 2020 Value Assessment Framework

As part of the public input process, IVI submitted comments on the Institute for Clinical and Economic Review’s (ICER) 2020 Value Assessment Framework. In May, ICER invited public comments as part of their process to update methods that underpin ICER reports. In summary, IVI wrote that value assessment must: • Provide flexible models that can […]
The Pros and Cons of the QALY: An AJMC Podcast with Jennifer Bright and Lou Garrison

After the panel presentation, “The Controversial QALY: Is There a Middle Ground in the Debate?” was wrapped up at ISPOR, AJMC deputy editor, Jaime Rosenberg, sat down with IVI’s Jennifer Bright and Lou Garrison (assistant director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington) to drill down further into the […]
IVI Moderated ISPOR Panel: The Controversial QALY

IVI Executive Director, Jennifer Bright, moderated a fascinating panel discussion on the quality-adjusted life-year (QALY) and whether there is room for a middle ground in the discussion about its merits and shortcomings. Lou Garrison, PhD, Assistant Director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington; Eleanor M. Perfetto, PhD, MS, […]
Jennifer Bright Addresses Differences Between Consumer-Driven and Patient-Centered Healthcare

IVI Executive Director, Jennifer Bright, writes in Morning Consult about the differences between patient-centered and consumer-driven healthcare. Read the full article here.
IVI’s Jeroen Jensen and Devin Incerti write in the Journal of Managed Care and Specialty Pharmacy

IVI’s Lead Scientific Advisor and Lead Economist for the Open-Source Value Platform (OSVP), Jeroen Jansen and Devin Incerti, respectively, collaborate with Jeffery Curtis in a recent article published in the Journal of Managed Care and Specialty Pharmacy about how IVI’s open-source approach to value assessment provides a way to adapt formal assessments of value—long the […]
“Good Enough” Doesn’t Cut it in Value Assessment

IVI’s Jennifer Bright and Mark Linthicum write in STAT News that we’re squandering time and resources trying to find a neat answer to “what is value?” by focusing on the cost of drugs without tackling other hard questions at the heart of measuring value across healthcare interventions. Determining the value of health care, they argue, […]
Steps Employers at the Crossroads of Healthcare Costs and Value Should Consider

IVI’s Jennifer Bright the president of the Institute for Integrated Benefits, Tom Parry, Ph.D., write in Fierce Healthcare that most employers have no idea how their benefit programs affect employee health outcomes. They outline a set of guiding principles to help employers take a more holistic approach – and foster a healthy, productive workforce – […]
Crowdsourcing for Value in Healthcare

Value-based healthcare is predicated on collaboration. Sharing of data, methods, pathways and perspectives among different stakeholders is paramount if the transition to value-based care is to be fully realized. Instead of relying solely on legacy methods to measure value, IVI’s Open-Source Value Platform (OSVP) uses a transparent and open-source process to develop methods and tools […]
Watch Mark Linthicum’s “101 Course” on IVI’s New Non-Small Cell Lung Cancer Value Model

IVI’s Director of Scientific Communications, Mark Linthicum, sits down with the Journal of Clinical Pathways for a webinar discussion about IVI’s open-source model for assessing value in non-small cell lung cancer therapies. If you want to learn more about IVI’s open-source approach to value assessment, this webinar is a great place to start. Click here to […]